Related Experiment Videos
Multimorbidity and risk among patients with established cardiovascular disease: a cohort study
Liam G Glynn1, Brian Buckley, Donal Reddan
1Department of General Practice, National University of Ireland, Galway, Ireland. liam.glynn@nuigalway.ie
Insights
High multimorbidity significantly increases mortality and cardiovascular events in patients with established cardiovascular disease. Chronic kidney disease and diabetes present similar mortality risks, highlighting multimorbidity
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
- Primary Care Medicine
Background:
- Multimorbidity is common in primary care, complicating patient management and risk assessment.
- Managing patients with multiple chronic conditions presents significant challenges for healthcare providers.
- Established cardiovascular disease often coexists with other chronic conditions like diabetes and kidney disease.
Purpose of the Study:
- To investigate the impact of chronic kidney disease and diabetes on mortality and morbidity in patients with existing cardiovascular disease.
- To assess the independent prognostic value of multimorbidity in patients with cardiovascular disease.
Main Methods:
- Retrospective cohort study involving 1609 patients with established cardiovascular disease.
- Data collected from 35 general practices in the west of Ireland, with a 5-year follow-up period.
- Primary endpoint: all-cause mortality. Secondary endpoint: cardiovascular composite endpoint (cardiovascular death, myocardial infarction, heart failure, peripheral vascular disease, stroke).
Main Results:
- Increased multimorbidity was significantly associated with higher risks of all-cause mortality and the cardiovascular composite endpoint (P<0.001).
- Patients with cardiovascular disease and diabetes showed similar survival to those with cardiovascular disease and chronic kidney disease.
- The presence of diabetes led to more cardiovascular events compared to chronic kidney disease in patients with cardiovascular disease.
Conclusions:
- The level of multimorbidity independently predicts prognosis in patients with established cardiovascular disease.
- Chronic kidney disease and diabetes confer similar mortality risks in patients with cardiovascular disease.
- Multimorbidity can be a valuable factor for prioritizing patient management in community settings with high cardiovascular risk.
Background:
Most patients managed in primary care have more than one condition. Multimorbidity presents challenges for the patient and the clinician, not only in terms of the process of care, but also in terms of management and risk assessment.
Aim:
To examine the effect of the presence of chronic kidney disease and diabetes on mortality and morbidity among patients with established cardiovascular disease.
Design Of Study:
Retrospective cohort study.
Setting:
Random selection of 35 general practices in the west of Ireland.
Method:
A practice-based sample of 1609 patients with established cardiovascular disease was generated in 2000-2001 and followed for 5 years. The primary endpoint was death from any cause and the secondary endpoint was a cardiovascular composite endpoint that included death from a cardiovascular cause or any of the following cardiovascular events: myocardial infarction, heart failure, peripheral vascular disease, or stroke.
Results:
Risk of death from any cause was significantly increased in patients with increased multimorbidity (P<0.001), as was the risk of the cardiovascular composite endpoint (P<0.001). Patients with cardiovascular disease and diabetes had a similar survival pattern to those with cardiovascular disease and chronic kidney disease, but experienced more cardiovascular events.
Conclusion:
Level of multimorbidity is an independent predictor of prognosis among patients with established cardiovascular disease. In such patients, the presence of chronic kidney disease carries a similar mortality risk to diabetes. Multimorbidity may be a useful factor in prioritising management of patients in the community with significant cardiovascular risk.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction